title: Consensus guidelines for therapeutic drug monitoring of rapamycin: report of the consensus panel.
authors.affiliation: Department of Laboratory Medicine & Pathology, University of Alberta, Edmonton, Canada.
authors.forename: R W
authors.initials: RW
authors.lastname: Yatscoff
authors.forename: R
authors.initials: R
authors.lastname: Boeckx
authors.forename: D W
authors.initials: DW
authors.lastname: Holt
authors.forename: B D
authors.initials: BD
authors.lastname: Kahan
authors.forename: D F
authors.initials: DF
authors.lastname: LeGatt
authors.forename: S
authors.initials: S
authors.lastname: Sehgal
authors.forename: S J
authors.initials: SJ
authors.lastname: Soldin
authors.forename: K
authors.initials: K
authors.lastname: Napoli
authors.forename: C
authors.initials: C
authors.lastname: Stiller
mesh_terms: D000818:Animals; D016903:Drug Monitoring; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D011090:Polyenes / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D020123:Sirolimus
chemical_list: D007166:Immunosuppressive Agents; D011090:Polyenes; D020123:Sirolimus